Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
New drug shows better results at preventing return of disease
December 28th, 2004
A newer drug prevented far more breast cancers from recurring in older women than the old standby tamoxifen and with far fewer side effects, doctors said December 8, 2004, citing a new study. Cancer specialists said Arimidex is likely to become the first-choice treatment for most women who have had the disease, and they predicted a wider role for similar drugs of its type, called aromatase inhibitors. New research suggests Arimidex might be able to prevent 70% to 80% of the most common type of tumors that occur in women after menopause, compared with the 50% that tamoxifen is credited with warding off. Women with early-stage...
Source: Cancer Weekly (2004-12-28)
|
